SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Guggenheim Initiates Coverage On ORIC Pharmaceuticals with Buy Rating, Announces Price Target of $45

Guggenheim initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $45.

Benzinga · 05/19/2020 11:43

Guggenheim initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $45.